Lian Zi Xin (Lotus Plumule)

Chinese Herb Actions

Chinese Herb Dosage

• What is the typical dosage of Lian Zi Xin?

  Roughly 1.5–6 g in decoction — a deliberately small range, because the plumule is far more concentrated and far more bitter than the seed body it comes from. This reference records 1.5–6 g and names the plumule and radicle as the part used; the wider materia medica literature clusters toward the lower end of that range (about 1.5–5 g).

  • As a powder — the traditional form when the aim is to stop bleeding, treat tongue ulceration, or astringe the essence, rather than to clear Heart fire in a decoction.
  • As an infusion — a few of the small green embryos steeped in hot water is a long-standing domestic preparation; the taste is markedly bitter, which is part of the herb’s identity rather than a fault of preparation.
  • Removed from Lian Zi — when a purely tonifying, non-draining effect is wanted from the lotus seed, the plumule is picked out and discarded (or kept for separate use). Whole seed and de-cored seed are therefore not interchangeable.

  Source: this reference’s own dosage record (1.5–6 g; plumule and radicle); standard materia medica ranges (Bensky; Chen & Chen), cross-referenced against multiple online sources. Reference only — not a prescription.

Chinese Herb Contraindications & Cautions

• Are there cautions for Lian Zi Xin?

  This reference records two: do not use in cases of constipation, or where there are abdominal masses. Beyond those, the herb’s bitter, cold, draining nature is itself the main caution — it is matched to genuine Heart fire (restlessness, agitation, insomnia with heat signs), and is not suited to cold or deficiency patterns, where prolonged use of a cold, draining herb can weaken Spleen and Stomach yang.

  • Small doses, short courses. Its recorded range (1.5–6 g) is one of the smallest in the fire-draining category; it is not a herb that is escalated.
  • Athletes under anti-doping rules. Lotus plumule naturally contains higenamine, which the World Anti-Doping Agency has listed as a prohibited beta-2 agonist since 2017. In a small human study, six participants who took 0.8 g of lotus plumule three times daily for three days all exceeded WADA’s urinary reporting threshold. Competing athletes should be aware that ordinary use of this herb can produce an adverse analytical finding — a regulatory fact, not a toxicity finding.

  Source: this reference’s own cautions record; materia medica consensus (Bensky; Chen & Chen); PMID 31973198 (Nutrients 2020;12(2):285, DOI 10.3390/nu12020285 — higenamine in lotus plumule products and human urinary study). Reference only, not a substitute for practitioner guidance.

Chinese Herb Toxicity & Overdose

• Low at customary doses. Lotus plumule is a food-adjacent substance — the green embryo is routinely separated from culinary lotus seeds, and is drunk on its own as a bitter tea — and no significant toxicity is reported in the traditional literature at the small doses used. The relevant modern caveat is regulatory rather than toxicological: the plumule naturally contains higenamine, a compound on the World Anti-Doping Agency prohibited list, so lotus-plumule products can produce a positive doping test in competitive sport. Higenamine occurs in the plumule partly as a glucoside shown in cell studies to act through the beta-2 adrenergic receptor, which is the pharmacological basis of that prohibited status.

  Source: PMID 31973198 (Nutrients 2020, lotus plumule products and human higenamine excretion); PMID 25943853 (Bioorg Med Chem 2015, higenamine 4′-O-glucoside in lotus plumule acting via the beta-2 adrenergic receptor, cell study). Reference note, not a safety guarantee.

Herb-Drug Interactions

• No well-established clinical herb–drug interactions are documented for Lian Zi Xin. Two areas warrant practitioner awareness, both resting on laboratory work with neferine (the plumule’s signature bisbenzylisoquinoline alkaloid) rather than on any observed clinical event:

  • Liver enzyme metabolism — an in-vitro study of CYP1A2, CYP2D6 and CYP3A4 inhibition found neferine had the lowest overall interaction potential of the three plant alkaloids tested, and the authors concluded that no clinically significant metabolic interaction seems likely. Reassuring rather than alarming, and included so the question is answered rather than left open.
  • Platelet function — neferine has been reported to inhibit platelet aggregation and to promote dissociation of platelet aggregates in laboratory work. Awareness is reasonable for patients on antiplatelet or anticoagulant medication; this is a theoretical, preclinical consideration, not a demonstrated clinical interaction.
  • Anti-doping — not a drug interaction, but the practical one: see Toxicity and Cautions regarding higenamine and WADA testing.

  Source: PMID 21678521 (Phytother Res 2012, in-vitro CYP inhibition); PMID 23773522 (Thromb Res 2013, neferine antiplatelet/antithrombotic, laboratory study). Flagged for practitioner confirmation — absence of documented interactions is not proof of safety.

Western / Biomedical Research

Chinese Herb Clinical Studies & Research

Provided as research context — a summary of published biomedical study, not a therapeutic or medical claim.

• Is there modern research on Lian Zi Xin (lotus plumule, Plumula Nelumbinis Nuciferae)?

  Yes — the plumule is the most chemically studied part of the lotus plant, but the evidence is preclinical (cell and animal), not clinical proof of any traditional indication. Its distinctive constituents are bisbenzylisoquinoline alkaloids — chiefly neferine, with liensinine and isoliensinine — which concentrate in the embryo and are largely absent from the seed body, a chemical fact that mirrors the traditional insistence that plumule and seed are different medicines.

  • Neferine, pharmacology review — a 2021 review in the Journal of Food Biochemistry compiles preclinical work on neferine across cardiovascular, central-nervous-system, anti-inflammatory, antioxidant and antiplatelet activity, noting its traditional association with high fever and poor sleep. A synthesis of in-vitro and animal data, not human trials.
  • Blood pressure, animal model — a 2020 Planta Medica study reported that neferine lowered systolic blood pressure in hypertensive rats without affecting heart rate, and relaxed isolated rat aorta through the nitric-oxide/soluble-guanylyl-cyclase pathway and calcium-channel modulation. A rat study: it offers a plausible mechanism behind the traditional note that this herb can temporarily lower blood pressure, but does not establish that effect in people.
  • Mood and cognition, animal models — lotus-plumule alkaloids reduced depression-like behaviour in a lipopolysaccharide-challenged mouse model (2019), and total alkaloids from the lotus seed embryo improved cognitive measures in APP/PS1 model mice and protected amyloid-damaged nerve-like cells (2023). Both preclinical.
  • Polysaccharide fraction — a 2021 study found a lotus-plumule polysaccharide showed prebiotic activity and improved insulin signalling in a liver cell line. Cell-level research only.

  Taken together, the modern literature confirms that the plumule is pharmacologically distinct from the seed and supplies plausible mechanisms for its calming and vascular effects, while human clinical evidence for Lian Zi Xin itself remains absent.

  Sources: PMID 34779018 (J Food Biochem 2021, neferine pharmacology review, DOI 10.1111/jfbc.13986); PMID 32219782 (Planta Med 2020, vasorelaxant and antihypertensive effects of neferine in rats); PMID 31486445 (Food Funct 2019, lotus-plumule alkaloids and depression-like behaviour in mice); PMID 36370050 (Nutr Neurosci 2023, seed-embryo total alkaloids in APP/PS1 mice); PMID 34071638 (Polymers 2021, lotus-plumule polysaccharide, cell study). Research context, not a therapeutic claim.

Chinese Herb Notes

• What is the difference between Lian Zi Xin (lotus plumule) and Lian Zi (lotus seed)?

  They are opposite in taste, temperature, and purpose, even though the plumule grows inside the seed. Lian Zi (lotus seed) is sweet, astringent and neutral: it tonifies the Spleen and Kidney and binds, treating deficiency and leakage. Lian Zi Xin, the green embryo at its centre, is bitter and cold: it drains, clearing Heart fire and settling an agitated spirit. Substituting one for the other reverses the intended effect — this contrast is the single most important thing to know about the herb.

  The lotus plant (Nelumbo nucifera) in the materia medica. Several distinct medicinals come from the one plant, each with its own name, part, and action:

  • He Ye (Lotus Leaf) — the leaf; clears Summerheat, raises clear yang, and (charred) stops bleeding.
  • Lian Zi (Lotus Seed) — the seed; tonifies Spleen and Kidney, stabilizes the essence, and calms the Heart.
  • Lian Zi Xin (Lotus Plumule) — this herb; the green embryo inside the seed; drains Heart fire and calms the spirit.
  • Ou Jie (Node of the Lotus Rhizome) — the rhizome node; stops bleeding, especially of the upper body.
  • Lian Geng (Lotus Stem) — the stem; unblocks qi circulation in the chest and diaphragm.
  • Lian Fang (Mature Lotus Receptacle) and Lian Xu (Lotus Stamen) — the seed-pod receptacle and the flower stamens, used for bleeding and for astringing the Kidney/securing essence respectively.

  Formula context: Lian Zi Xin is best known as an ingredient of Qing Gong Tang (Clear the Palace Decoction) from the Wen Bing Tiao Bian — a warm-disease formula assembled almost entirely from the “hearts” or cores of cooling herbs (the plumule of the lotus seed, the tips of bamboo leaf, the core of forsythia fruit), on the classical reasoning that the heart of a plant reaches the Heart of the patient. That formula is not among those held in this reference; it is given here as classical background. (Traditional formula context, not treatment advice.)

  Character note: this reference records the Chinese as “连子心”. The standard written form of the lotus is 莲 (lián, lotus), not 连 (lián, to link/connect) — so the expected form is 莲子心. The same substitution appears in this reference’s Lian Zi entry, while its Lian Fang (莲房) and Lian Xu (莲须) entries use the correct character, and the pharmaceutical Latin (Plumula Nelumbinis Nuciferae) confirms the lotus. Left unchanged in the identity field pending owner confirmation; flagged for the data-quality list.

  Source: this reference’s own records for the lotus-derived herbs (identity, properties, categories); classical formula background cross-referenced against multiple online sources and materia medica consensus (Bensky; Chen & Chen).